StockWatch
·

TORRENT PHARMACEUTICALS LTD. Q3 FY26 Results

TORNTPHARMQ3 FY26 Results
Filing
MetricValue (₹ Cr)Q2 FY26Q3 FY25
Revenue3.3K0.0%17.6%
Total Income3.3K0.5%15.8%
Expenditure2.5K0.2%14.6%
PBT814.002.9%17.8%
Net Profit635.007.5%26.2%
OPM32.64%0.24pp18.33pp
NPM19.30%1.25pp1.60pp
EPS18.777.6%26.1%
View full financials

Informational and educational content only. Not investment advice.